New! Price transparency was meant to lower costs. In a large NY RCT, it instead raised charges ~1% (driven by lower-priced providers with few out-of-network patients) with no change in patient behavior -- likely helping providers benchmark, not consumers shop. journals.uchicago.edu/doi/10.1086/...